Skip to main content

Table 1 Patient characteristics

From: Visual outcome is similar in optic neuritis patients treated with oral and i.v. high-dose methylprednisolone: a retrospective study on 56 patients

 

All patients (n = 56)

Oral (n = 28)

i.v. (n = 28)

Gender (female/male)

42/14

20/8

22/6

Median age (range) (years)

 

33 (23 to 60)

35 (18 to 60)

Median duration of symptoms before treatment (range) (days)

 

7 (1 to 35)

7 (1 to 30)

Median total dose MP (range) (grams)

 

3.0 (1.5 to 5)

3.0 (2.8 to 6)

Median treatment duration (range) (days)

 

3 (3 to 5)

3 (3 to 6)

Median follow-up time (range) (weeks)

 

9 (4 to 24)

9 (4 to 24)

Multiple sclerosis before treatment (number of patients)

13

5

8

Undergoing disease-modifying therapy for MS (number of patients)

8

2

6

Previous ON in other eye (number of patients)

8

5

3